-
Indo US Bio-Tech Strengthens Collaboration with UK's Exco Inהיוזמות
Indo US Bio-Tech Limited, a leading Indian pharmaceutical company, has announced the expansion of its collaboration with Exco Inהיוזמות, a UK-based biopharmaceutical company. The strengthened partnership aims to accelerate the development and commercialization of novel therapeutic solutions for unmet medical needs.
-
Indo US Bio-Tech Reports Strong Financial Performance in Q3 FY23
Indo US Bio-Tech Limited has reported robust financial performance for the third quarter (Q3) of the fiscal year 2022-23 (FY23). The company's revenue grew significantly, driven by strong demand for its products and operational efficiency.
-
Indo US Bio-Tech Collaborates with icddr,b to Enhance Healthcare Access in Bangladesh
Indo US Bio-Tech Limited has partnered with the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) to improve healthcare access and strengthen research capabilities in Bangladesh. The collaboration aims to make essential medicines and diagnostic tools more widely available and affordable.
-
Indo-US Bio-Tech Announces the Launch of its new product - TAVNEB
INDO-US BIO-TECH (IUB), a subsidiary of the Hyderabad-based INDO-US VENTURES LTD (IUVL), today announced the launch of a new product - TAVNEB - as part of its anti-viral therapeutic strategy.
-
Indo-US Bio-Tech Receives GMP Certificate from UK MHRA
INDO-US BIO-TECH (IUB), a subsidiary of the Hyderabad-based INDO-US VENTURES LTD (IUVL), has received a Good Manufacturing Practices (GMP) certificate from the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) for its manufacturing facility at Genome Valley, Hyderabad.
-
Indo-US Bio-Tech Signs MoU with IICT for Joint Research and Development
INDO-US BIO-TECH (IUB), a subsidiary of the Hyderabad-based INDO-US VENTURES LTD (IUVL), has signed a Memorandum of Understanding (MoU) with the Indian Institute of Chemical Technology (IICT), Hyderabad, for joint research and development in the areas of biotechnology and pharmaceuticals.
-
Indo US Bio-Tech Limited Announces Q2FY23 Results
The Company reported a strong performance in Q2FY23 with Revenue from Operations at INR 144.7 Crores, marking a growth of 21.2% YoY and 14.5% QoQ.
-
Indo US Bio-Tech Limited's Q1FY23 Results: Revenue up 18.5% YoY
Indo US Bio-Tech Limited reported its financial results for Q1FY23 on July 29, 2022, showcasing a robust performance despite the challenging macroeconomic environment.
-
Indo US Bio-Tech Limited Appoints Mr. Nikhilesh Singh as CEO
Indo US Bio-Tech Limited, a leading Indian biopharmaceutical company, has announced the appointment of Mr. Nikhilesh Singh as its new Chief Executive Officer (CEO), effective May 2, 2022.
-
Indo US Bio-Tech Limited Launches New Anti-Cancer Drug
Indo US Bio-Tech Limited, a leading Indian biopharmaceutical company, has launched a new anti-cancer drug called 'IU-B01' in India.
-
Indo US Bio-Tech Announces Deployment of Bio Fertilizer Plant in West Bengal, India
Indo US Bio-Tech Limited (Indo US Bio-Tech), a leading player in the bio-agri inputs industry, has announced the installation of a state-of-the-art bio fertilizer manufacturing plant in West Bengal, India. The new facility, located in Purulia district, will significantly enhance the company's production capacity and enable more efficient distribution of bio fertilizer products across eastern India.
-
Indo US Bio-Tech Appoints Industry Veteran Dr. Nagendra Singh as Chief Technology Officer
Indo US Bio-Tech Limited (Indo US Bio-Tech) has announced the appointment of Dr. Nagendra Singh as its Chief Technology Officer (CTO). Dr. Singh brings over three decades of experience in the bio-agri industry, with a focus on research and development of innovative bio-tech solutions for sustainable agriculture. In his role as CTO, Dr. Singh will lead the company's R&D efforts and drive the development of next-generation bio-fertilizers and bio-pesticides.
-
Indo US Bio-Tech Limited Announces Q3 FY23 Results
The company reported a consolidated revenue of Rs 440.7 crore, up by 23.6% YoY.
-
Indo US Bio-Tech Limited Partners with Leading Healthcare Provider
The partnership aims to enhance access to innovative healthcare solutions.
-
Indo US Bio-Tech Limited Receives Prestigious Industry Award
The company was recognized for its commitment to excellence in healthcare.
